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ABSTRACT 
 
Aim: The primary aim of this systematic review was to evaluate the effect of various 
techniques used for vertical ridge augmentation on clinical vertical bone gain. 
Material and Methods: A protocol was developed to answer the following focused question: 
“In patients with vertical alveolar ridge deficiencies, how effective are different augmentation 
procedures for clinical alveolar ridge gain?” Randomized and controlled clinical trials and 
prospective and retrospective case series were included, and meta-analyses were performed 
to evaluate vertical bone gain based on the type of procedure and to compare bone gains in 
controlled studies. 
Results: Thirty-six publications were included. Results demonstrated a significant vertical bone 
gain for all treatment approaches [n=33; weighted mean effect = 4.16 mm; 95% CI 3.72-4.61; 
p<0.001]. Clinical vertical bone gain and complications rate varied among the different 
procedures, with a weighted mean gain of 8.04 mm and complications rate of 47.3% for 
distraction osteogenesis, 4.18 mm and 12.1% for guided bone regeneration (GBR) and 3.46 
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mm and 23.9% for bone blocks. In comparative studies, GBR achieved a significant greater 
bone gain when compared to bone blocks [n=3; weighted mean difference=1.34 mm; 95% CI 
0.76-1.91; p<0.001]. 
Conclusions:  Vertical ridge augmentation is a feasible and effective therapy for the 
reconstruction of deficient alveolar ridges, although complications are common. 
 
 
Clinical Relevance 
Scientific rationale for study: Bone atrophy often hinders the adequate placement of dental 
implants. Different techniques have been proposed to augment the ridge vertically in order to 
improve bone support. 
Principal findings: Vertical ridge augmentation (VRA) procedures are effective in treating 
deficient alveolar ridges irrespective of the technique used. However, the rate of associated 
complications should not be underestimated.  
Practical implications: Clinicians should be aware that VRA is a highly demanding therapy. The 
decision-making process for the ideal treatment should be made on the basis of site and 
patient related factors, in combination with surgical experience and skill.  
 
Introduction 
Vertical ridge augmentation (VRA) is one of the greatest challenges for bone regeneration in 
implant dentistry.  This is primarily due to technique sensitivity and, consequently, frequent 
intra- and post-operative complications (Fontana, Maschera, Rocchietta, & Simion, 2011; 
Rocchietta, Fontana, & Simion, 2008; Tinti & Parma-Benfenati, 1998). VRA aims to achieve 
bone regeneration without osseous wall containment (i.e., bony walls to support the stability 
of the clot and the bone graft), and for this reason, it is biologically demanding, as 
angiogenesis must reach a certain distance from existing bone for new bone to be formed 
(Wang & Boyapati, 2006; Wikesjo, Kean, & Zimmerman, 1994). In addition, the soft tissue has 
to be advanced to provide a closed healing environment for the increased dimensions of the 
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alveolar ridge, requiring a correct flap design and tension-free flap approximation (Urban, 
Monje, Lozada, & Wang, 2017).   
Due to the associated comorbidities of augmentation procedures, such as post-operative 
infections, wound dehiscences or neurosensory disorders, other approaches besides VRA have 
been proposed (e.g., short dental implants). These therapeutic modalities have proven to be 
effective and valid alternative treatments to sinus floor elevation or VRA, with reduced 
morbidity and high patient satisfaction (Hammerle & Jung, 2003; Nisand, Picard, & Rocchietta, 
2015; Salvi, Monje, & Tomasi, 2018; Thoma, Haas, et al., 2015; Thoma, Zeltner, Husler, 
Hammerle, & Jung, 2015). However, in cases with limited bone availability for placing short 
implants, or due to restorative considerations, VRA may be the best therapy choice as it offers 
an opportunity for augmenting lost bony structure and often leads to improved esthetic 
outcomes (Salvi et al., 2018). 
 
Several therapeutic modalities have been proposed for VRA, namely distraction osteogenesis 
(DO) (Froum, Rosenberg, Elian, Tarnow, & Cho, 2008), bone blocks (either as onlays or inlays/ 
interpositional grafts) (Chiapasco, Brusati, & Ronchi, 2007; Chiapasco, Zaniboni, & Rimondini, 
2007), and guided bone regeneration (GBR) (Hammerle & Jung, 2003). Even though these 
therapies have been widely investigated within the last three decades, the most suitable 
approach remains unclear, in particular regarding the relative effectiveness of these 
techniques for vertical clinical bone gain (VCBG). While the use of autologous block grafts has 
been described as the “gold standard” for severe atrophies (Tessier et al., 2005), advances in 
the field of biomaterials have favored the use of less invasive approaches (i.e., GBR). In an 
attempt to develop clinical guidelines, systematic reviews have been conducted to assess the 
outcomes of clinical investigations. The most recent reviews have demonstrated that VRA, 
regardless of the intervention carried out, can achieve on average ~4mm of vertical bone gain 
(Elnayef et al., 2017; Milinkovic & Cordaro, 2014). However, these reviews were focused on 
specific anatomical areas, or were not aimed at assessing relevant secondary outcome 
variables such as implant-related outcomes, intra- and post-operative complications, or 
patient-reported outcomes. 
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Therefore, it seems reasonable to evaluate the effectiveness of vertical bone augmentation, to 
correlate it with associated complications and to explore peri-implant health outcomes over 
time. This systematic review was performed as required by group 4 (regeneration of alveolar 
ridge defects) in preparation for the XV European Worksop in Periodontology held in La Granja 
de San Ildefonso (Segovia, Spain) between 11 and 14 November, 2018.  
 
Material and methods 
Protocol development and focused question 
The protocol followed the PRISMA (Preferred Reporting Items for Systematic Review and 
Meta-Analyses) statement (Moher, Liberati, Tetzlaff, & Altman, 2009). The review protocol 
was registered and allocated the identification number CRD42018088189 in the PROSPERO 
International Prospective Register of Systematic Reviews hosted by the Centre for Reviews and 
Dissemination, University of York, National Institute for Health Research (United Kingdom).  
The protocol aimed at answering the following focused question: “In patients with vertical 
alveolar ridge deficiencies (population), how effective are vertical bone augmentation 
procedures (intervention and comparison) attaining clinical alveolar ridge gain (primary 
outcome)?”  
 
Eligibility criteria 
Inclusion criteria  
 Population: patients older than 18 and in good general health with vertical ridge 
deficiencies in need of an implant-supported/-retained prosthesis; 
 Interventions: any given intervention for VRA; 
 Comparisons: any given intervention for VRA in controlled studies; 
 Outcomes: changes in the clinical vertical dimension of the ridge;  
 Study design: randomized clinical trials (RCTs), controlled clinical trials (CCT’s), 
prospective/ retrospective cohort studies or prospective/ retrospective case series (CS) 
with a minimum of 10 patients (5 per group in controlled studies). 
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Exclusion criteria 
• Studies assessing the effectiveness of interventions aimed only at horizontal bone 
regeneration; 
 Studies assessing the effectiveness of VRA procedures using only radiographs; 
 Studies aiming at regenerating extractions sockets before or simultaneous with 
implant placement; 
 Studies evaluating solely maxillary sinus floor elevation;  
 Studies including only oncologic and poly-traumatized patients; 
 Orthognathic procedures aiming at changing the bone dimensions for different 
purposes than tooth replacement. 
 
Type of intervention and comparisons 
Studies were selected that included interventions for VRA. The following procedures were 
considered: (1) GBR; (2) bone blocks, either as onlay or inlay grafts; (3) distraction 
osteogenesis; (4) other approaches. Inlay graft was used as a synonym for interpositional graft. 
Moreover, the following biomaterials were assessed: (1) autogenous bone grafts; (2) 
allogeneic bone grafts; (3) xenogeneic bone grafts. 
 
Type of outcomes 
The primary outcome for assessing VRA was the change in the clinical vertical alveolar ridge 
dimension, as determined by direct linear measurements between baseline and re-entry.  
 
The following secondary outcomes were studied: 
 Surgical intra- and post-operative complications, including the need for re-grafting, 
flap dehiscence, graft or membrane exposure, loss of graft integration, local infection, 
prolonged pain, paresthesia, etc; 
 Implant survival and success rates (%); 
 Changes in marginal bone levels, defined as the distance between the implant 
shoulder and the first bone to implant contact measured at both mesial and distal 
aspects (mm); 
 Probing pocket depth (PPD); 
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 Gingival or bleeding indexes; 
 Occurrence of biological complications (%) defined as the occurrence of mucositis 
(bleeding on probing with or without increased PPD and without radiographic bone 
loss) and/or peri-implantitis (BOP with or without increased PPD and with radiographic 
bone loss - (Lang & Berglundh, 2011); 
 Patient-reported outcome measures (PROMs), such as pain, discomfort, satisfaction, 
etc. 
 
For the secondary outcome measurements related to implants, only studies with a minimum 
follow-up of 12-months after definitive loading were considered. 
 
Information sources and search 
Electronic search 
Three electronic databases were used as sources in the search for studies satisfying the 
inclusion criteria: (1) The National Library of Medicine (MEDLINE via PubMed); (2) Cochrane 
Central Register of Controlled Trials; and (3) Embase. These databases were searched for 
studies published up until January 2018. The search was limited to human subjects. 
 
Manual search 
All reference lists of the selected studies and previously published systematic reviews were 
checked for cross-references. The following journals were hand-searched from year 2008 to 
2018: Journal of Clinical Periodontology, Journal of Periodontology, Clinical Oral Implants 
Research, International Journal of Oral & Maxillofacial Implants, European Journal of Oral 
Implantology, Implant Dentistry, International Journal of Oral and Maxillofacial Surgery, 
Journal of Oral and Maxillofacial Surgery, The International Journal of Periodontics and 
Restorative Dentistry and Clinical Implant Dentistry and Related Research. 
 
Search strategy 
Information on the search strategy can be accessed in the Supplemental Methods. 
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Screening methods 
Two reviewers (ISS and EM) did the primary search by independently screening the titles and 
abstracts. The same reviewers selected full manuscripts of studies meeting the inclusion 
criteria, or those with insufficient data in the title and abstract to make a clear decision. Any 
disagreement was resolved by discussion with a third reviewer (AM). The inter-reviewer 
reliability (percentage of agreement and kappa correlation coefficient) of the full-text analysis 
was calculated.  
 
Data extraction 
The same two reviewers performed duplicate data extraction. When data was incomplete or 
missing, authors of studies were contacted for clarification. If agreement could not be reached, 
data was excluded until further clarification was available. When the results of a study were 
published more than once, only the longest follow-up was included. 
 
Quality assessment (risk of bias in individual studies) 11-12 
The Newcastle-Ottawa scale (NOS) for cohort studies and a modification of the scale for cross-
sectional studies were used for the assessment of risk of bias in individual observational 
studies and non-randomized trials (Wells et al. 2011). This scale includes 3 main categories: 
selection of study groups, comparability of participants, and outcome. Each individual study 
received a maximum of 6 points in CS and 7 points in CCT’s. 
 
A quality assessment of the included RCT’s was performed according to the Cochrane 
Handbook for Systematic Reviews of Interventions Version 5.1.0 (Higgins & Green, updated 
March 2011,) and the CONSORT statement (Moher et al., 2012). Seven main quality 
parameters were assessed: sequence generation, allocation concealment, blinding of 
participants and personnel (performance bias), blinding of outcome assessment (detection 
bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias) 
and other sources of bias. These parameters were rated to be in low risk of bias if all the 
criteria were met.  
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Risk of bias across studies 
The publication bias was evaluated using a Funnel plot and the Egger´s linear regression 
method for the clinical vertical ridge dimension changes. A sensitivity analysis of the meta-
analysis results was also performed for this outcome (Tobias & Campbell, 1999). 
 
Data analyses 
The statistical heterogeneity among studies was assessed using the Q test based on chi-square 
statistics (Cochrane, 1954) as well as the I2 index (Higgins, Thompson, Deeks, & Altman, 2003) 
in order to know the percentage of variation in the global estimate that was attributable to 
heterogeneity.  
 
To summarize and compare studies, mean values of primary and secondary outcomes were 
directly pooled and analyzed with weighted mean differences (WMDs) and 95% confidence 
intervals (CIs). Study specific estimates were pooled with both the fixed and random-effect 
models (DerSimonian & Laird, 1986). If a significant and high heterogeneity was found, then 
the random-effect model results were presented. Two groups of meta-analyses were 
performed based on study design: (1) when comparing different techniques for VRA, only RCTs 
or CCTs were included; (2) when comparing mean changes of the studied outcomes between 
final and baseline visits, CS and each test arm of RCTs and the CCTs were included (Sanz-
Sanchez, Ortiz-Vigon, Sanz-Martin, Figuero, & Sanz, 2015). In addition, subgroup analyses were 
performed on the selected main outcome variable using the study design, the unit of analysis, 
the time of implant placement and the type of intervention as explanatory variables.   
 
A Forest Plot was created to illustrate the effects of the different studies and the global 
estimation. STATA® (StataCorp LP, Lakeway Drive, College Station, Texas, USA), and 
OpenMeta[Analyst] intercooled software was used to perform all analyses. Statistical 
significance was defined as a p value <0.05.  
 
Results 
Search  
Figure 1 depicts the flow chart summarizing the results of the selection. The electronic and 
manual search rendered 3925 titles, which, after evaluating their titles and abstracts, resulted 
in 348 articles for full text analysis.  After this analysis, 36 final articles were included for data 
extraction, which represented 34 independent investigations, since results of the same studies 
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reported at different time points were excluded (Merli, Lombardini, & Esposito, 2010; Merli, 
Migani, & Esposito, 2007; Merli et al., 2014) [agreement=87.36%; kappa=0.76; 95% CI (0.64-
0.89); p<0.001]. The reasons for excluding the remaining studies are detailed in Supplementary 
Table 1. 
 
Description of selected studies 
Table 1 depicts the methodological characteristics of the selected studies. Out of the 34 
investigations, 16 were prospective CS, 8 retrospective CS, 4 CCT’s and 6 RCT’s (5 had a parallel 
design and 1 a split-mouth design). All the controlled studies compared two arms, whereas 
only one study among the CS evaluated three different treatment approaches, so data from 
each experimental group was analyzed independently (Simion, Jovanovic, Tinti, & Benfenati, 
2001). Moreover, in one study three different particulate grafts were used, although the 
results were pooled together (Fontana, Grossi, Fimano, & Maiorana, 2015). Simultaneous 
implant placement was performed in 11 studies, whereas the stage approach was used in 20 
investigations. Additionally, there were 3 investigations in which staged and simultaneous 
approaches were combined together (Beitlitum, Artzi, & Nemcovsky, 2010; Fontana et al., 
2015; Urban, Jovanovic, & Lozada, 2009), with only one study giving the results separately 
(Fontana et al., 2015). One of the included CS evaluated both horizontal and vertical bone 
augmentation and met the inclusion criteria (Anitua, Alkhraisat, & Orive, 2013). However, the 
authors did not report the number of patients/implants within each group and; therefore, 
relevant data could not be used for most of the analyses. Among the controlled studies, 3 
compared GBR procedures using different grafts, 3 compared GBR procedures using different 
membranes, and 4 compared onlay grafts to GBR procedures. 
 
The resulting systematic review pooled data from 678 patients at baseline, with a total of 
1,392 implants. Six studies did not report the number of implants placed (Anitua et al., 2013; 
Funato, Ishikawa, Kitajima, Yamada, & Moroi, 2013; Leong et al., 2015; Rocchietta et al., 2016; 
Roccuzzo, Ramieri, Bunino, & Berrone, 2007; Urban, Lozada, Jovanovic, Nagursky, & Nagy, 
2014). Among the 34 included investigations, 14 reported the results up until re-entry surgery 
only, which was carried out between 4.6 and 10.41 months. The remaining 20 clinical studies 
followed the implants for a mean period of 36.80 ± 9.35 months, with a range between 12-73 
months. At the end of the follow-up period, among the studies included in this systematic 
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review, 668 patients and a total of 1,309 implants were analyzed. Additionally, 13 
investigations reported on tobacco consumption.  
 
Risk of bias in individual studies 
A total of 26 non-randomized studies were evaluated using the NOS Scale. A mean value of 2.6 
(min: 2, max: 3) was achieved for the section “Selection.” Five trials were appropriate for 
“Comparability,” where a mean value of 1 (min = 1, max = 1) was obtained. For the section 
“Exposure/Outcome,” a mean value of 2.14 (min = 2, max = 3) was obtained (Supplementary 
Table 2).  
 
The Cochrane tool was used to score the randomized clinical trials. A total of 6 studies could be 
scored. All the studies were scored with 2 stars in the sections concerning the randomization 
and allocation. For the sections that concerned “bias,” a total of 12 stars were achieved, giving 
a mean of 2.00 (min = 1, max = 4). Two studies achieved a low risk of bias in the main 6 criteria 
(Supplementary Table 3). 
 
Risk of bias across studies 
No significant publication bias was observed when combining all controlled studies for the 
primary outcome measure (p = 0.746). However, a statistically significant publication bias was 
observed for the same outcome when combining all studies, both controlled and not 
controlled (p < 0.001). The sensitivity analyses showed that the exclusion of a single study did 
not substantially alter any estimate. 
 
Effects of Interventions 
Primary outcome: changes in the clinical alveolar ridge vertical dimension  
Table 2 depicts the meta-analysis evaluating clinical vertical bone gain. For all studies, there 
was a statistically significant vertical bone gain (n=33; WME=4.16 mm; 95% CI 3.72-4.61; 
p<0.001). Based on the type of intervention, the maximum vertical bone augmentation was 
reported for distraction osteogenesis (n=3; WME=8.04 mm; 95% CI 5.68-10.41; p<0.001), 
whereas the minimum gain was reported for particulate, synthetic graft alone (n=1; 
WME=2.05 mm; 95% CI 1.44-2.66; p<0.001 - Figure 2). GBR was the most frequently reported 
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procedure (n=20), with the majority of studies employing non-resorbable membranes (n=13). 
Case series demonstrated greater vertical bone gain than RCT’s or CCT’s. In regard to the time 
of implant placement, the staged approach achieved a weighted mean gain of 4.39 mm (n=21; 
WME=4.39 mm; 95% CI 53.71-5.06; p<0.001) and the simultaneous approach of 3.81 mm 
(n=12; WME=3.81mm; 95% CI 53.31-4.30; p<0.001). 
 
Distraction osteogenesis for vertical alveolar ridge augmentation 
Owing to the small sample size (n=3) and to the nature of this approach (graftless procedure), 
no variables could be sub-analyzed. 
 
Guided bone regeneration for vertical alveolar ridge augmentation: effect of type of particulate 
grafting material and barrier membrane upon the primary outcome 
Within non-resorbable membranes, the most commonly used graft was particulate autologous 
bone (n=6). There were more studies evaluating expanded PTFE (PTFE-e) (n=11; WME=4.31 
mm; 95% CI 3.80-4.82; p<0.001) than dense PTFE (PTFE-d) membranes (n=3; WME=4.99 mm; 
95% CI 4.03-5.95; p<0.001). Moreover, the type of graft used underneath influenced the 
clinical bone gain (Table 2).  
 
When using a resorbable membrane, the vertical bone gain was 3.51 mm; (n=7; 95% CI 2.80-
4.22; p<0.001), while for non-resorbable membranes it was 4.42 mm; (n=13; 95% CI 3.97-4.87; 
p<0.001). Cross-linked membranes achieve a bone gain of 4.19 (n=4; WME=4.19 mm; 95% CI 
3.18-5.21; p<0.001) and native collagen membranes 2.66 mm (n=3; WME= 2.66 mm; 95% CI 
1.49-3.82; p<0.001). Again, the type of graft used underneath influenced the outcome, so as 
providing a space maintainer by means of a titanium mesh or plate (Table 2). 
 
Block grafts for vertical alveolar ridge augmentation: effect of type of block grafting material 
upon the primary outcome 
The second most frequently reported procedure was block grafts (n=12; WME=3.46 mm; 95% 
CI 2.71-4.22; p< 0.001). Based on the nature of the graft, the results were heterogeneous and 
the vertical bone gain ranged from 4.12 mm for autologous bone (n=7; WME=4.12 mm; 95% CI 
3.11-5.13; p< 0.001), to 2.03 mm for allograf bone (n=4; WME=2.03 mm; 95% CI 1.88-2.18 p< 
0.001). The impact of the technique used with autologous bone influenced the outcome (Table 
2). Due to the heterogeneity of the type of membrane/ barrier used, no sub-analysis was 
performed regarding covering or not covering the block. 
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Table 3 depicts the meta-analysis comparing vertical bone gain among interventions (RCTs or 
CCTs).  Within the five possible comparisons, two were based on three studies, one was based 
on two studies and two on single trials. When comparing GBR procedures to onlay blocks, 
significantly better results were yielded for GBR (n=3; WMD= 1.34 mm; 95% CI 0.76-1.91; 
p<0.001). Also, adding a Titanium mesh to an autogenous onlay block led to higher vertical 
bone gain (n=1; WMD=1.20 mm; 95% CI 0.04-2.36; p<0.001). No significant differences 
between the test and control groups were found for other comparisons.  
 
Secondary outcomes 
Surgical intra- and post-operative complications 
The incidence of complications was assessed in all the studies except one (Jensen, Kuhlke, 
Bedard, & White, 2006). Seven publications reported no complications. The most common 
complications were membrane and graft exposures with or without infection. The incidence 
and description of complications in each individual study is depicted in Table 4.  
 
The meta-analysis was performed on all studies except five, since three studies combined the 
complication rates for vertical and horizontal bone augmentation (Anitua et al., 2013; Nissan, 
Gross, et al., 2011; Nissan, Mardinger, Calderon, Romanos, & Chaushu, 2011), one study 
combined different approaches within the same surgical site (Rocchietta et al., 2016), and one 
study reported a range of complications (Jensen, Cockrell, Kuhike, & Reed, 2002). The overall 
complication rate was 16.9% (n=29; Weighted mean incidence (WMI) =16.9%; 95% CI 12.5-
21.2; p< 0.001), with higher values for controlled studies than for case series. In regard of the 
time of implant placement the complication rate was 22.3% for the staged approach (n=15; 
WMI=22.3%; 95% CI 13.4-31.3; p< 0.001) and 11.8% for the simultaneous approach (n=11; 
WMI=11.8%; 95% CI 6.7-17; p< 0.001). The type of procedure also influenced the rate of 
complications with a 47.3% rate for distraction osteogenesis (n=2; WMI=47.3%; 95% CI 0.0-98; 
p< 0.001), 12.1% for GBR (n=20; WMI=12.1%; 95% CI 8.2-15.9; p< 0.001) and 23.9% for the use 
of blocks (n=9; WMI=23.9%; 95% CI 11.3-36.6; p< 0.001). Within GBR, non-resorbable 
membranes have a complication rate of 6.9% (n=13; WMI=6.9%; 95% CI 4.1-9.7; p< 0.001) and 
resorbable membranes of 22.7% (n=8; WMI=22.7%; 95% CI 11.5-33.9; p< 0.001) (Table 5). 
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Implant survival and success 
Implant survival was reported in 27 studies. The aggregated mean implant survival rate was 
98.95% (range 90.5-100%). For controlled studies, implant survival was 100% in both groups, 
whereas for the CS, the mean implant survival was 98.35%. Implant success using specific 
criteria was reported in 7 studies. In 6 studies the Albrektsson & Zarb criteria (Albrektsson & 
Zarb, 1998) were used, reporting an implant success rate between 85.33 and 100% (Fontana et 
al., 2015; Froum et al., 2008; Llambes, Silvestre, & Caffesse, 2007; Mangano et al., 2014; 
Simion et al., 2001; Urban et al., 2009). One study used a modification of the Albrektsson & 
Zarb criteria, reporting implant success rates of 94.2% (Chiapasco, Consolo, Bianchi, & Ronchi, 
2004). 
 
Changes in marginal bone levels  
Marginal bone levels with at least 12-months follow-up were evaluated in 11 investigations. 
The values were reported either as the mean of the mesial and distal scores at the end of the 
follow-up (Canullo & Malagnino, 2008; Llambes et al., 2007) or as the mean change in bone 
levels (bone loss) by comparing the final and baseline evaluations (Canullo & Sisti, 2010; 
Chiapasco et al., 2004; Fontana et al., 2015; Fontana et al., 2008; Merli et al., 2014; Todisco, 
2010; Urban et al., 2009). The meta-analysis revealed that there was a significant bone loss 
over time (n=9; WMD=1.01 mm; 95% CI 0.78-1.24; p< 0.001). The type of procedure also 
influenced the outcome and bone loss ranged from 1.40 mm for distraction osteogenesis (n=1; 
WMD=1.40 mm; 95% CI 1.33-1.47; p< 0.001) to 0.58 mm for GBR with resorbable membranes 
(n=1; WMD=0.58 mm; 95% CI 0.19-0.97; p< 0.001 - Supplementary Table 4). 
 
Probing depth  
Probing depth (PD) was assessed in 4 out of the 34 investigations. In one study the mean PD at 
the end of the follow-up was reported only for the test group (Fontana et al., 2008), whereas 
in two other studies the final scores for each arm were reported (Simion et al., 2001; Urban et 
al., 2009), and one study reported only the initial values at prosthesis delivery (Roccuzzo, 
Ramieri, Spada, Bianchi, & Berrone, 2004). Due to the scarcity and the inconsistency of this 
outcome, no meta-analysis was performed.  
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Gingival or bleeding indexes 
Inflammation of the peri-implant soft tissues was assessed in 3 out of the 34 investigations, 
either as bleeding on probing or as the modified sulcus bleeding index. One study reported 8% 
of bleeding on probing (BOP) at the end of the study, pooling the data for implants receiving 
horizontal and vertical augmentation (Nissan, Gross, et al., 2011), whereas another revealed 
18.2% at prosthesis delivery (Roccuzzo et al., 2004). In the study by Simion et al., 2001, the 
modified sulcus bleeding varied from 0.16 to 0.39 among the three study arms. No meta-
analysis was performed for this outcome. 
 
Biological complications  
The occurrence of biological complications based on case definitions was only evaluated in two 
investigations. One study reported that 3.73% of the implants had progressive bone loss >2 
mm plus BOP (Urban et al., 2009), and the other that 0% of the implants had progressive bone 
loss >3 mm plus BOP (Merli et al., 2014). Additionally, three studies reported that 5.8-20% of 
the implants had bone loss above the criteria defined by Albrektsson & Zarb (Chiapasco et al., 
2004; Fontana et al., 2015; Llambes et al., 2007). 
 
Patient reported outcomes (PROM’s) 
Finally, PROM’s were reported only in one investigation, showing that patient esthetic 
perception was less than optimal in 8 out of 10 cases (Jensen et al., 2002). 
 
Discussion  
Primary findings  
The results from this systematic review, based on 36 publications reporting data from 34 
investigations, indicate a high variability in terms of VRA interventions. Furthermore, the 
available evidence is derived mostly from case series (24 investigations) and a small number of 
comparative studies (10 investigations), showing that VRA studies have provided primarily low 
levels of evidence (Richards 2009). For this reason, the results presented in the systematic 
review should be interpreted with caution. 
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The main findings of the meta-analysis, based on the changes between final and baseline 
values, show that these interventions significantly augment the clinical vertical ridge 
dimension, which was influenced by the type of intervention. 
 
GBR was identified as the most frequently used intervention for VRA (nstudies=18). The concept 
of GBR is based on the creation of a secluded space to allow the protected migration of 
osteoblasts (Melcher, 1976). Accordingly, form-stable devices (i.e., titanium reinforced non-
resorbable membranes, or resorbable membranes plus space maintainers such as titanium 
meshes or osteosynthesis plates) may enhance vertical bone gain. On the other hand, 
resorbable barrier membranes without any space maintenance features apart from the graft 
may collapse and achieve less bone gain. Among the types of resorbable membranes, the 
chemical process of cross-linking affects enzymatic degradation leading to prolonged 
biodegradation of these membranes, which could influence the final result (Melcher, 1976).  
 
Block grafts (nstudies=14) were shown to be a feasible option for VRA, achieving a clinical bone 
gain of ~3.5mm. Nevertheless, it should be stressed that vertical bone gain was influenced by 
the type of technique used with autologous grafts and by the nature of the graft. The meta-
analysis for comparative clinical trials showed the superiority of GBR in terms of vertical bone 
gain compared to onlay block grafts based on 3 studies (WMD ~1.4 mm). 
 
Secondary findings 
Based on no direct comparisons, distraction osteogenesis reported the highest complication 
rate (47.3%), followed by blocks (23.9%) and GBR (12.1%). Interestingly, resorbable 
membranes were more prone to complications than non-resorbable membranes (~23% versus 
~7%), which is in line with previous systematic reviews (Elnayef et al., 2017; Lim, Lin, Monje, 
Chan, & Wang, 2018; Milinkovic & Cordaro, 2014). Since complication rates were high 
irrespective of the time of implant placement and taking into consideration that 
graft/membrane exposures were frequent and that postoperative infections may lead to a 
bacterial contamination of adjacent implant surfaces, it is speculated that staged VRA might be 
exposed to less severe complications. 
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It could be hypothesized that more caution is used when applying non-resorbable barriers, as 
post-operative complications derived from membrane exposure are more difficult to manage. 
PTFE-d membranes were less prone to complications than PTFE-e membranes (~4% vs. ~8%). 
This observation could be related to PTFE-e’s lower cell occlusivity (larger pore size), which 
might lead to easier penetration of putative bacteria that could compromise graft healing 
outcomes (De Sanctis, Zucchelli, & Clauser, 1996). 
 
The aggregated mean implant survival rate (nstudies=27) was comparable to previous studies 
reporting implants placed in pristine sites (Pjetursson, Asgeirsson, Zwahlen, & Sailer, 2014; 
Pjetursson, Thoma, Jung, Zwahlen, & Zembic, 2012; Salvi et al., 2018). However, bone level 
changes were seldom reported (nstudies=9). In addition, only 2 studies with long-term follow-up 
reported on biological complications based on specific case definitions (Merli et al., 2014; 
Urban et al., 2009). Hence, considering the limited data and the confounder effect of implant 
time in function, no conclusions could be drawn regarding the stability of peri-implant tissues 
around implants placed in VRA bone. 
 
Agreements and disagreements with previous systematic reviews 
The effectiveness of the different interventions described for VRA has been a subject of debate 
for years. As such, diverse systematic reviews have been published within the last decade to 
assess different techniques. The first review was published as part of the 6th European 
Workshop on Periodontology (Rocchietta et al., 2008). At that time the variability within the 
studies considered for the review did not allow a meta-analysis to be performed.  Later and 
based on 8 trials, Esposito and co-workers demonstrated that more vertical bone gain could be 
achieved with distraction osteogenesis than with interpositional grafts (mean difference: 
3.25mm) and with bone substitutes rather than with autogenous bone for GBR (mean 
difference: 0.6mm) (Esposito et al., 2009). However, insufficient data provided unclear 
conclusions regarding the most effective technique.  
 
The results reported in the present systematic review are in agreement with a previously 
published review, which concluded that vertical defects can be successfully treated with GBR 
or bone block grafts, with a high complication rate for distraction osteogenesis (Milinkovic & 
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Cordaro, 2014). Moreover, Elnayef et al demonstrated the plausibility of VRA in the posterior 
mandible regardless of technique (mean vertical bone gain ~4.5mm), with less complications 
for GBR procedures (Elnayef et al., 2017).  
 
Limitations and recommendations for future research 
In the present review, caution is required before interpreting the principal findings due to the 
high heterogeneity between studies, conflicting inter-study outcomes, uncontrolled 
confounders inherent in each study design and to the multiple sub-types of interventions. 
Further, it must be noted that the different interventions were performed by a wide array of 
clinicians in different environments, with different levels of surgical training and using different 
biomaterials and instruments. 
 
While evidence may indicate that bone gain occurs using VRA in severely resorbed distal 
extensions or fully edentulous cases, the same may not true for vertical ridge deficiencies 
around single implants with mesial and distal bone peaks. However, none of the RCTs included 
in the present systematic review evaluated a negative control to better understand this issue. 
As a result, some factors potentially affecting implant outcomes, particularly implant 
supported single crowns in resorbed ridges (i.e., crown-to-implant ratio or abutment length), 
could not be evaluated. Moreover, most of the included studies mixed different clinical 
conditions without sub-analyzing the data, which could have an impact on outcomes. 
 
The method used for VRA measurement, including pre- (baseline defect extension) and post-
operative (vertical bone gain) evaluation, was not homogeneous across the included studies. 
The vast majority of studies used a periodontal probe to evaluate defect depth and bone 
obtained after VRA, but the placement of the probe in relation to the adjacent dentition, the 
type of probe and its placement along the augmented bone were inconsistent across the 
studies.  Along these lines, it is important to emphasize that trials assessing vertical bone gain 
via radiographs (two- or three-dimensional) were excluded from the systematic review 
because of inaccuracies assessing hard tissue gain and considering the heterogeneity of 
scattering, energy settings, exposure time, field of view and beam hardening artifacts (Rios, 
Borgnakke, & Benavides, 2017). Moreover, the long-term fate of the augmented bone and the 
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implant outcomes (including biological, technical complications and survival rates) are unclear, 
as only isolated, low level evidence reports containing disparate findings were available. 
 
It must be emphasized that the aforementioned shortcomings should be overcome in future 
studies. As such, the authors encourage future researchers to conduct double-blind, 
randomized and controlled trials with long-term follow-up (≥5 years after implant loading) in 
different clinical environments and with multiple investigators. It would be beneficial if such 
future studies included incidence of biological complications and PROM’s for different VRA 
techniques so they might also be compared with minimally invasive approaches (e.g., short 
dental implants). 
 
Within the limitations of the present systematic review, it can be concluded that VRA is a 
reasonable therapy for the reconstruction of deficient alveolar ridges.  Given the body of 
scientific evidence from the eligible studies included in the present systematic review, no clear 
conclusions can be drawn regarding the superiority of any particular VRA technique. 
Nonetheless, it seems that GBR, especially when combined with non-resorbable barrier 
membranes, offers effective VRA with low post-operative complication rates. 
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Figure Legends 
 
Figure 1. Flow chart depicting the article selection process. 
 
Figure 2. Forrest-plots for clinical vertical bone gain based on the type of procedure. 
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Table 1. Methodological characteristics of the included studies. 
 
Authors/ 
Year 
Study  
design 
Type of 
procedure 
Test (graft 
presentatio
n) 
Type of 
procedure 
Control 
(graft 
presentatio
n) 
Treatment  
Definition  
Test (Staged, 
Simultanous) 
 
Treatmen
t  
Definition  
Control 
(Staged, 
Simultane
ous) 
Graft 
origin and  
Test (T) 
Control 
(C) 
Number of 
patients 
baseline 
(final)/sites 
baseline 
(final) 
Number 
of 
Implants  
baseline 
(final) 
Follo
w-up 
of 
impla
nts. 
Mean 
(range
) 
Study 
outcom
es 
measur
ed 
Type of measure to 
assess vertical bone 
gain 
Condition 
evaluated and 
Mean CBG (mm) 
 
Artzi et al. 
2003 
Case 
series 
(prosp
) 
 
Titanium 
mesh only 
(Particulate) 
 
NC Titanium mesh + 
xenograft  
 
(Staged) 
NC Xenograft  
 
 
10 
(10)/10(10) 
20(20) Only 
re-
entry 
CBG, 
COM, IS 
Probe to record the 
depth between the 
supporting screw head 
base and the current 
crestal augmented 
area. 
 
Posterior maxilla 
and mandible 
involving more 
than one tooth 
 
5.2±0.79 
Canullo & 
Sisti  2010 
Case 
series 
(prosp
) 
 
GBR 
(Particulate) 
 
NC PTFE-e titanium 
reinforced membrane + 
magnesium-enriched 
hydroxyapatite 
 
(Simultaneous) 
NC Synthetic 
graft  
 
20 
(20)/20(20) 
42(42) 24 CBG, 
COM, IS, 
BL 
Periodontal probe to 
measure exposed 
implant surface 
Single or partial 
anterior or 
posterior maxilla 
or mandible 
 
5.85±1.48 
Cardaropoli  
et al. 2013 
Case 
series 
(prosp
) 
 
GBR 
(Particulate) 
 
NC Xenograft + fibrin- 
fibronectin sealing + 
native collagen 
resorbable membrane  
 
(Simultaneous) 
NC Xenograft  
 
20 
(20)/20(20) 
35(35) Only 
re-
entry 
CBG, 
COM, IS 
Periodontal probe to 
measure exposed 
implant surface 
Single or partial 
anterior or 
posterior maxilla 
or mandible 
 
3.94±1.47 
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Chiapasco  
et al. 2004 
Case 
series 
(prosp
) 
 
Distraction 
(No graft) 
NC Intra-osseous distactor 
 
(Staged) 
NC No graft  
 
37(37)/37(3
7) 
138(138) 34 
(15-
55) 
CBG, 
COM, IS, 
ISUC, BL 
Number of rotations 
od the distraction 
device 
Full or partial 
anterior or 
posterior maxilla 
or mandible 
 
9.9±3.4 
Corrente et 
al. 1997 
Case 
series 
(prosp
) 
 
Particulate 
graft only 
 
NC Calcium 
carbonate+fibrin- 
fibronectin sealing (no 
membrane) 
 
(Simultanous) 
NC Synthetic 
graft  
 
11(11)/11(1
1) 
22(22) Only 
re-
entry 
CBG, 
COM, IS 
Periodontal probe to 
measure exposed 
implant surface 
Single or partial 
anterior or 
posterior maxilla 
or mandible 
 
2.05±1.47 
De Stavola & 
Tunkel 2013 
Case 
series 
(prosp
) 
 
Onlay 
(Particulate 
and block) 
 
NC Autologous bone using   
the shell technique  
 
(Staged) 
 
NC Autologous  
 
10(10)/10(1
0) 
18(18) 12 CBG, 
COM, IS 
One periodontal 
probe placed 
horizontally al the 
bone picks and 
another placer 
vertically to the base 
of the bone 
Single or partial 
anterior or 
posterior maxilla 
or mandible  
 
6±1.29 
Llambés et 
al. 2007 
Case 
series 
(prosp
) 
 
GBR 
(Particulate) 
 
NC Autologous + xenograft 
+cross-linked 
resorbable membrane  
 
(Simultaneous) 
 
NC Autologous 
+ 
xenograft  
11 
(11)/13(13) 
32 (30) 12 CBG, 
COM, IS, 
ISUC, BL, 
Periodontal probe to 
measure exposed 
implant surface 
Partial posterior 
mandible 
 
2.89±1.25 
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Mangano et 
al. 2014 
Case 
series 
(prosp
) 
 
Onlay 
 
NC Custom made 
Hydroxyapatite 
(milling from a block)  
 
(Staged) 
NC Synthetic 
graft  
 
10(10)/10(1
0) 
10(10) 12 CBG, 
COM, IS, 
ISUC 
One periodontal 
probe placed 
horizontally al the 
bone picks and 
another placer 
vertically to the base 
of the bone 
Single anterior or 
posterior maxilla 
or mandible 
 
3.7±0.82 
Nissan et al. 
2011a 
Case 
series 
(prosp
) 
 
Onlay 
 
NC Freeze-dried 
cancellous allograft  
 
(Staged) 
NC Allograft  20(20)/NR 31(30) 42 
(12-
65) 
CBG, 
COM, IS 
BOP 
Periodontal probe to 
the base of the bone 
Single or partial 
anterior maxilla  
 
2±0.5 
Nissan et al. 
2011b 
Case 
series 
(prosp
) 
 
Onlay 
 
NC Freeze-dried 
cancellous allograft  
 
(Staged) 
NC Allograft  34(31)/NR 63(62) 34 (6-
59) 
CBG, 
COM, IS 
BOP 
Periodontal probe to 
the base of the bone 
Single or partial 
anterior maxilla  
 
2±0.5 
Peleg et al. 
2010 
Case 
series 
(prosp
) 
 
Onlay 
 
NC Allogenic cortico-
cancellous iliac  graft 
 
(Staged) 
NC Allograft  13(13)/16(1
6) 
26(26) 26 CBG, 
COM, IS 
Distance between the 
screw head and the 
cortical aspect of the 
graft 
Single or partial 
anterior or 
posterior maxilla 
or mandible  
 
2.4±1.09 
Roccuzzo et 
al. 2004 
Case 
Series 
(prosp
) 
 
Onlay + 
Titanium 
mesh 
 
 
NC Autologous block from 
ramus/symphysis + 
Titanium mesh 
 
(Staged) 
NC Autologous  
 
18(18)/18(1
8) 
37(37) Only 
re-
entry 
CBG, 
COM, IS, 
PPD, 
BOP 
One periodontal 
probe placed 
horizontally at the 
CEJ of the neighbour 
tooth and another 
placer vertically to 
the base of the bone 
Single or partial 
anterior or 
posterior maxilla 
or mandible  
 
4.8±1 
Todisco 
2010 
Case 
Series 
(prosp
GBR 
(Particulate) 
NC PTFE-e titanium 
reinforced membrane + 
xenograft 
NC Xenograft  
 
20(20)/25(2
5) 
64(64) 12 VBG, 
COM, IS, 
One periodontal 
probe placed 
horizontally al the 
Single or partial 
anterior or 
posterior maxilla 
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) 
 
  
(Staged) 
 
BL CEJ /bone picks of 
the neighbour tooth 
and another placer 
vertically to the base 
of the bone 
or mandible  
 
5.24±1.5 
Urban et al. 
2014 
Case 
series 
(prosp
) 
 
GBR 
(Particulate) 
 
NC PTFE-d titanium 
reinforced membrane + 
autologous bone chips+ 
xenograft(1:1) 
 
(Staged) 
NC Autologous 
+  
xenograft 
(1:1)  
 
19(19)/20(2
0) 
NR Only 
re-
entry 
VBG, 
COM 
One periodontal 
probe placed 
horizontally al the 
bone picks and 
another placer 
vertically to the base 
of the bone 
Partial anterior 
or posterior 
maxilla or 
mandible  
 
5.45±1.93 
Yu et al. 
2016 
Case 
series 
(prosp
) 
 
Onlay 
(Particualte+
Block) 
 
 
 
Autologous bone using   
the shell technique 
 
(Staged) 
 Autologous  
 
21(21)/21(2
1) 
21(21) 73 
(48-
96) 
VBG, 
COM 
One periodontal 
probe placed 
horizontally al the 
CEJ /bone picks of 
the neighbour tooth 
and a calliper placer 
vertically to the base 
of the bone 
Single or partial 
anterior maxilla  
 
5.12±1.05 
Jensen et al. 
2002 
Case 
series 
(prosp
) 
 
Distraction 
(no graft) 
 
NC Distraction implant or 
an orthodontic screw 
device 
 
(Staged) 
NC No graft  28(28)/30(3
0) 
48(40) 60 
 
CBG, IS, 
PROM’s, 
COM 
Measuring the length 
of the distraction 
implant 
Partial anterior 
maxilla 
 
6.5±1.4 
Anitua et al. 
2013 
Case 
series 
(ret) 
Particulate 
graft only 
 
NC Autologous + xenograft 
(when needed) + PRGF  
 
(Simultaneous) 
NC Autologous 
+ 
xenograft  
NR 80 (NR) 26 CBG, 
COM, IS 
BL 
  
Periodontal probe to 
measure exposed 
implant surface 
Partial posterior 
mandible 
 
1-3 (range) 
Canullo & 
Malagnino  
2008 
Case 
series 
(ret) 
GBR 
(Particulate) 
NC PTFE-e titanium 
reinforced membrane + 
xenograft  
NC Xenograft  10(10)/10(1
0) 
24(24) 36  
(24-
54) 
CBG, 
COM, IS, 
BL 
Periodontal probe to 
measure exposed 
implant surface 
Partial anterior 
or posterior 
maxilla or 
mandible  
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
   
(Simultaneous) 
 
5.37±1.5 
Fontana et 
al. 2015 
Case 
series 
(ret) 
 
GBR 
(Particulate) 
 
NC Autologous only, 
allograft only or 
xenograft+auto-logous 
1:1 + PTFE-e titanium 
rein-forced membrane  
 
(Staged or 
Simultaneous) 
 
NC Autologous 
(n=7); 
Allograft 
(n=5)  
Autologous
+ 
xenograft 
(n=17)  
21(21)/29(2
9) 
75(73) 42 
(12-
72) 
CBG, 
COM, IS, 
ISUC, BL 
Distance between the 
top of the tenting 
screw or implant 
shoulder and the first 
visible bone-screw 
contact 
Partial posterior 
mandible 
 
4.14±1.33 
Froum et al. 
2008 
Case 
series 
(ret) 
 
Distraction 
(No graft) 
 
NC Distraction with intra-
osseous or extra-
osseous distractors 
 
(Staged) 
NC No graft  30(30)/30(3
0) 
55(50) (34-
60) 
CBG, 
COM, IS, 
ISUC 
Periodontal probe to 
measure from one 
hole of the upper 
distractor to a hole in 
the lower 
Partial anterior 
or posterior 
maxilla or 
mandible  
 
7.8±4.9 
Funato et al. 
2013 
Case 
series 
(ret) 
 
GBR 
(Particulate) 
NC Autologous + xenograft 
+ cross-linked 
resorbable membrane 
+ rhPDGF+ Titanium 
mesh  
 
(Staged) 
NC Autologous 
+ 
xenograft  
19(19)/19(1
9) 
NR Only 
re-
entry 
CBG, 
COM 
Periodontal probe to 
measure from the 
base of the defect to 
the most coronal hole 
of the titanium mesh 
Partial anterior 
or posterior 
maxilla or 
mandible  
 
8.6±4 
Jensen et al. 
2006 
Case 
series 
(ret) 
 
Inter-
positional 
graft (Inlay) 
 
NC Interpositional graft 
using a cortical wedge 
obtained from the 
ramus 
 
NC Autologous  
 
10(10)/10(1
0) 
15(15) 60 CBG, 
COM, IS 
One periodontal 
probe placed 
horizontally al the 
CEJ /bone picks of 
the neighbour tooth 
and a calliper placer 
vertically to the base 
Partial anterior 
maxilla 
 
4.2±0.92 
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(Staged) 
 
of the bone 
Simion et al. 
2001 
Case 
Series 
(ret) 
3  
arms 
GBR 
(Particulate) 
 
 
NC 
PTFE-e titanium 
reinforced membrane + 
T1: blood clot 
T2: DFDBA  
T3:Autologous 
 
(Simultaneous) 
NC T1: Blood 
clot  
T2: 
Allograft 
T3: 
Autologous 
49(49)/54(5
4) 
T1: 6 
(6)/7(7) 
T2: 11 
(11)/11(11) 
T3: 32 
(32)/36(36) 
123 (122) 
T1: 17 
(16) 
T2: 24 
(24) 
T3: 82 
(82) 
 
(16-
69) 
 
CBG, 
COM, IS, 
ISUC, BL, 
PPD 
BOP 
Periodontal probe to 
measure exposed 
implant surface 
Partial anterior 
or posterior 
maxilla or 
mandible  
 
T1: 2.89±1.22 
T2: 3.26±0.88 
T3: 3.79±1.7 
Urban et al. 
2009 
Case 
Series 
(ret) 
 
GBR 
(Particulate) 
 
NC PTFE-e titanium 
reinforced membrane + 
autologous bone  
 
(Staged or 
Simultaneous) 
NC Autologous  
 
35(35)/36(3
6) 
82(82) 40.3 
(12-
72) 
CBG, 
COM, IS, 
ISUC, BL, 
PPD 
BIC 
One periodontal 
probe placed 
horizontally al the 
bone picks and 
another placer 
vertically to the base 
of the bone or 
periodontal probe to 
measure exposed 
implant surface 
Full, single or 
partial anterior 
or posterior 
maxilla or 
mandible  
 
5.5±2.29 
Beitlitum et 
al. 2010 
CCT 
 
GBR 
(Particulate) 
 
GBR 
(Particulate) 
 
Autologous bone + 
FDBA+cross-linked 
resorbable membrane 
 
(Staged or 
Simultaneous) 
FDBA+cros
s-linked 
resorbable 
membrane 
(Staged or 
Simultano
us) 
Autologous 
+ 
allograft 
(T) 
Allograft 
(C) 
 
 
23(23)/23(2
3) 
51(51) Only 
re-
entry 
CBG, 
COM, IS 
Periodontal probe to 
measure exposed 
implant surface 
Single or partial 
anterior or 
posterior maxilla 
or mandible  
 
T: 3.5±1.2 
C: 3.47±1.25 
Rocchietta 
et al. 2016 
CCT  Onlay + 
membrane 
GBR Autologous + PTFE-e 
titanium reinforced 
Autologou
s+ PTFE-e 
titanium 
Autologous 
(T & C) 
10(10)/12(1
2) 
NR Only 
re-
CBG, 
COM 
Distance from the 
base of the bone to 
the head of the 
Partial posterior 
mandible 
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  (Particluate) membrane 
 
(Staged) 
reinforced 
membrane 
 
(Staged) 
 entry titanium screw  
T: 2.91±0.92 
C: 4.45±0.85 
Roccuzzo et 
al. 2007 
CCT 
 
Onlay + 
Titanium 
mesh 
 
Onlay Autologous from 
ramus/symphysis + 
Titanium-mesh 
 
(Staged) 
Autologou
s from 
ramus/sy
mphysis  
 
(Staged) 
Autologous 
(T & C) 
 
23(23)/24(2
4) 
NR Only 
re-
entry 
CBG, 
COM,  
One periodontal 
probe placed 
horizontally al the 
CEJ of the neighbour 
tooth and another 
placer vertically to 
the base of the bone 
Single or partial 
anterior or 
posterior maxilla 
or mandible  
 
T: 4.8±1.5 
C:  3.6±1.4 
Simion et al. 
1998 
CCT 
 
GBR 
(Particulate) 
 
GBR 
(Particulate) 
 
PTFE-e titanium 
reinforced membrane + 
DFDBA  
 
(Simultaneous) 
PTFE-e 
titanium 
reinforced 
membrane 
+ 
autologous 
bone  
 
(Simultane
ous) 
Allograft 
(T) 
Autologous 
(C) 
 
20 
(20)/22(22) 
26 (26) Only 
re-
entry 
CBG, 
COM, IS 
Periodontal probe to 
measure exposed 
implant surface 
Partial anterior 
or posterior 
maxilla or 
mandible  
 
T: 3.14±0.9 
C: 5.02±2.3 
Abrahamsso
n 
et al. 2012 
RCT 
(parall
el) 
GBR 
(Particulate) 
 
Onlay Soft tissue expander + 
autologous + titanium 
mesh + native collagen 
resorbable membrane  
 
(Staged) 
 
Autologou
s graft 
 
(Staged) 
Autologous 
(T & C) 
 
 
 
20 
(20)/20(20) 
23(23) Only 
re-
entry 
CBG, 
COM, IS 
T: probe from the 
crest to the mesh. 
 
C: probe to measured 
graft resoption at the 
screws 
 
Single or partial 
anterior maxilla 
 
T: 3±1.4 
C:  1.6±0.8 
Merli et al. 
2014, 2010, 
RCT 
(parall
GBR GBR Native collagen 
resorbable membrane 
e-PTFE 
titanium 
Autologous 22(21)/22(2 77(74) 72 CBG, Periodontal probe to 
measure exposed 
Single or partial 
anterior or 
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2007 el) 
 
(Particulate) 
 
(Particulate) 
 
supported by 
osteosynthesis plates + 
autologous 
 
(Simultaneous) 
 
reinforced 
membrane 
+ 
autologous 
(Simultane
ous) 
(T & C) 
 
1) COM, BL 
BIC 
implant surface posterior maxilla 
or mandible  
 
T: 2.16±1.51 
C: 2.48±1.13 
Ronda et al. 
2014 
RCT 
(parall
el) 
 
GBR 
(Particulate) 
 
GBR 
(Particulate) 
 
d-PTFE titanium 
reinforced membrane + 
autologous + allograft 
50:50 
 
(Simultaneous) 
e-PTFE 
titanium 
reinforced 
membrane 
+ 
autologous 
+ allograft 
50:50 
(Simultane
ous) 
Autologous 
+ allograft 
(T & C) 
 
23(23)/26(2
6) 
38(38) (15-
37) 
CBG, 
COM, IS 
Periodontal probe to 
measure exposed 
implant surface 
Partial posterior 
mandible 
 
T: 5.49±1.58 
C: 4.91±1.78 
Cucchi et al. 
2017 
RCT 
(parall
el) 
 
GBR 
(Particulate) 
 
GBR 
(Particulate) 
 
Allograft+ autologous 
(50:50)+ titanium 
mesh+ cross-linked 
collagen membrane  
(Simultaneous) 
Allograft+ 
autologous 
(50:50)+ 
PTFE-d 
titanium 
reinforced 
membrane 
(Simultane
ous) 
Autologous 
+ 
allograft (T 
& C) 
 
40(35)/40(3
5) 
 
99 (99) 
 
Only 
re-
entry 
CBG, 
COM, IS 
Periodontal probe to 
measure exposed 
implant surface 
Partial posterior 
mandible 
 
T: 4.1±1 
C: 4.2±1 
Leong et al. 
2015 
RCT 
(parall
el) 
 
Onlay+Memb
rane 
 
GBR 
(Particulate) 
 
Allograft + native 
collagen resorbable 
membrane 
(Staged) 
Cancellous 
and 
cortical 
allograft + 
native 
collagen 
resorbable 
membrane 
Allograft 
(T & C) 
 
16(16)/19 
(19) 
NR Only 
re-
entry 
CBG, 
COM 
Periodontal probe 
with a surgical stent 
Partial posterior 
mandible 
 
T: 1.78±2.3 
C: 1±2.2 
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(Staged) 
Fontana et 
al. 2008 
RCT 
(split)  
 
GBR 
(Particulate) 
 
GBR 
(Particulate) 
Allograft +PTFE-e 
titanium reinforced 
membrane)  
(Staged) 
Autologou
s +PTFE-e 
titanium 
reinforced 
membrane
)  
(Staged) 
Allograft 
(T) 
Autologous 
(C) 
5(5)/10(10) 25(25) 24 
(12-
36) 
CBG, 
COM, IS, 
BL, PPD 
Distance from the 
base of the bone to 
the head of the 
titanium screw 
Partial posterior 
mandible 
 
T: 4.7±0.48 
C: 4.1±0.88 
 
prosp: prospective; NC: no control; T: test; C: control; GBR: guided bone regeneration; PTFE-e: expandend Polytetrafluoroethylene; PTFE-d: dense Polytetrafluoroethylene; ret: retrospective; DFDBA: 
demineralized freeze dried bone allograft; FDBA: freeze dried bone allograft; rh-PDGF: recombinant human platelet derived growth factor; CCT: controlled clinica trial; PRGF: platelet rich growth factors; 
RCT: randomized clinical trial; CBG: Clinical Bone Gain; COM: Complication IS: Implant survival, ISUC: Implant success, BL: Marginal bone levels assessed radiograohically; PPD: Peri-implant probing depth; 
BOP: Bleeding on Probing; BIC: Biological implant complication; PROMs: patient reported outcomes.; CEJ: cement-enamel junction; NR: Not reported 
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Table 2. Meta-analysis for vertical bone augmentation: Final vs. Baseline (mm) 
 
Group:Subgroup n Weighted Mean Effect Heterogeneity 
IV DL 95% CI P value I2 P value 
All 33  4.164 3.716 4.612 <0.001 96.5 <0.001 
Study design         
RCT (all) 6  3.358 2.599 4.117 <0.001 93.3 <0.001 
RCT (split) 1 4.562  4.193 4.932 <0.001 - - 
RCT (parallel) 5  3.128 2.260 3.997 <0.001 93.0 <0.001 
CCT 4  3.826 3.287 4.365 <0.001 83.4 <0.001 
Case Series 23  4.670 3.978 5.362 <0.001 97.7 <0.001 
Unit of analysis         
Patient 23  4.401 3.904 4.897 <0.001 94.5 <0.001 
Implant/Site 10  3.582 2.920 4.244 <0.001 96.4 <0.001 
Time of implant placement         
Staged 21  4.386 3.707 5.065 <0.001 97.6 <0.001 
Simultaneous 12  3.808 3.312 4.303 <0.001 90.3 <0.001 
Intervention         
1. Distraction osteogenesis 3  8.044 5.678 10.409 <0.001 93.6 <0.001 
2. Guided Bone Regeneration 20  4.179 3.797 4.560 <0.001 89.7 <0.001 
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2.1. Non resorbable membrane 13  4.422 3.974 4.870 <0.001 89.4 <0.001 
2.1.1. Non resorbable membrane 
(PTFE-e) 
11  4.310 3.801 4.818 <0.001 90.2 <0.001 
2.1.2. Non resorbable membrane 
(PTFE-d) 
3  4.986 4.027 5.946 <0.001 81.3 0.005 
2.1.3. Non resorbable + particulate 
autologous   
6  4.210 3.408 5.011 <0.001 88.5 <0.001 
2.1.4. Non resorbable membrane + 
particulate allograft   
3  3.702 2.683 4.722 <0.001 93.9 <0.001 
2.1.5. Non resorbable membrane + 
particulate xenograft   
2 5.277  4.780 5.774 <0.001 0.0 0.817 
2.1.6. Non resorbable membrane + 
particulate synthetic graft   
1 5.850  5.201 6.499 <0.001 - - 
2.1.7. Non resorbable membrane + 
particulate autologous + 
particulate allograft   
2  4.793 3.949 5.637 <0.001 71.4 0.030 
2.1.8. Non resorbable membrane + 
particulate autologous + 
particulate xenograft   
1 5.450  4.604 6.296 <0.001 - - 
2.2. Resorbable membrane 8  3.513 2.801 4.225 <0.001 87.2 <0.001 
2.2.1. Resorbable membrane + 
space maintainer (Ti-mesh/plate) 
4  4.263 2.588 5.938 <0.001 93.4 <0.001 
2.2.2. Resorbable membrane 
without space maintainer 
4  3.185 2.510 3.861 <0.001 75.3 0.001 
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2.2.3. Native collagen resorbable 
membrane 
4  2.659 1.493 3.825 <0.001 86.6 <0.001 
2.2.4. Cross-linked resorbable 
membrane 
4  4.195 3.183 5.207 <0.001 89.0 <0.001 
2.2.5.  Resorbable membrane + 
particulate autologous 
2  2.587 1.764 3.410 <0.001 42.9 0.186 
2.2.6. Resorbable membrane + 
particulate allograft 
2  2.336 -0.076 4.749 <0.001 88.4 0.003 
2.2.7. Resorbable membrane + 
particulate xenograft 
1 3.950  3.463 4.437 <0.001 - - 
2.2.8. Resorbable membrane + 
particulate autologous + 
particulate allograft   
2  3.901 3.347 4.455 <0.001 33.7 0.220 
2.2.9. Resorbable membrane + 
particulate autologous + 
particulate xenograft   
1 2.890  2.151 3.629 <0.001 - - 
2.2.10 Resorbable membrane + 
particulate autologous + 
particulate xenograft + rhPDGF 
1 8.600  6.801 10.399 <0.001 - - 
2.3. Titanium mesh (without 
membrane) 
1 5.200  4.710 5.690 <0.001 - - 
2.3.1. Titanium mesh + particulate 
xenograft 
1 5.200  4.710 5.690 <0.001 - - 
3. Blocks 12  3.464 2.706 4.222 <0.001 97.2 <0.001 
3.1. Autologous bone block 7  4.118 3.109 5.126 <0.001 95.9 <0.001 
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3.1.1. Autologous onlay block 4  3.530 2.209 4.851 <0.001 96.0 <0.001 
3.1.2. Autologous interpositional 
block 
1  4.200 3.630 4.770 <0.001 - - 
3.1.3. Shell technique 2  5.495 4.642 6.348 <0.001 71.2 0.060 
3.2. Allograft bone block 4 2.030  1.880 2.179 <0.001 0.0 0.556 
3.3. Xenograft block 1 3.700  3.192 4.208 <0.001 - - 
4. Particulate synthetic graft 1 2.050  1.436 2.664 <0.001 - - 
 
 
IV, inverse-variance weighted (fixed effect) model; DL, DerSimonian and Laird (random effect) model; CI, confidence interval; RCT, randomized clinical trial; CCT, 
controlled clinical trial 
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Table 3. Meta-analysis for differences in vertical bone augmentation for comparative studies: Test vs Control (mm) 
 
Control Test  Weighted Mean Difference Heterogeneity 
n IV/DL 95% CI P value I2 P value 
Onlay Block Guided Bone 
Regeneration 
3a,b,c 1.336 0.762 1.911 <0.001 29.2 0.243 
Autologous Onlay Block Autologous Onlay Block 
+ Ti-mesh 
1d 1.200 0.039 2.361 0.042 - - 
Non resorbable 
membrane 
Resorbable membrane + 
space maintainer 
2e,f -0.156 -0.720 0.408 0.587 0.0 0.738 
Guided Bone 
Regeneration + 
particulate autologous 
Guided Bone 
Regeneration + 
particulate allograft 
3g,h,i -0.440 -1.961 1.081 0.571 0.0 0.394 
PTFE-e membrane + 
particulate autologous + 
particulate allograft 
PTFE-d membrane + 
particulate autologous + 
particulate allograft 
1j 0.58 -0.800 1.960 0.410 - - 
 
IV, inverse-variance weighted (fixed effect) model; DL, DerSimonian and Laird (random effect) model; CI, confidence interval 
a Abrahamsson et al. (2012); b Leong et al. (2015); c Rocchietta et al. (2016); d Roccuzzo et al. (2007); e Merli et al. (2007); f Cucchi et al. (2017); g Fontana et al. 
(2008); h Beitlitum et al. (2010); I Simion et al. (1998); j Ronda et al. (2014).  
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Table 4. Surgical intra- and post-operative complications. 
Reference Procedure % Complications  Specifications of complications 
Artzi et al. 
2003 
T: Titanium mesh  T: 20 2 cases with exposure of the titanium mesh. Implants could be 
places without any problem. 
Canullo & Sisti 
2010 
T: GBR T: 5 1 patient presented a late exposure at 8 weeks and the 
membrane was immediately removed. The complication didn't 
jeopardize the implant or the VBA. 
Cardaropoli et 
al. 2013 
T: GBR T: 0 No complication occurred  
Chiapasco  et 
al. 2004 
T: Distraction T: 22 1 case with mandibular fracture. 5 cases with mandibular or 
palatal inclination of the segment. 1 case with incomplete 
distraction and 1 case with the need of secondary bone grafting 
Corrente et 
al. 1997 
T: Particulate graft 
only 
 
T: 0   
No cases with exposure of the graft material. 
 
De Stavola 
&Tunkel 2013 
T: Onlay T: 0 No exposure of the graft and no complications with the donor 
site. 
Llambés et al. 
2007 
T: GBR T: 27.3 2 cases with oral perforation by the implant at 3 months and 1 
case with exposure and implant failure. 
Mangano et 
al. 2014 
T: Onlay 
 
T: 10   
One graft was exposed 2 months after the procedure and the 
most coronal portion of the graft had to be removed. 
Peleg et al. 
2010 
T: Onlay 
 
T: 0 No cases with exposure of the graft material. 
Roccuzzo et 
al. 2004 
T: Onlay + Ti-mesh 
 
T: 38.9 Temporary paraesthesia observed in 5 cases (27.8%). Exposure of 
the Ti-mesh in 4 patients (22.2%).  
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Todisco  2010 T: GBR T: 8 2 patients presented membrane exposure. 
Urban et al. 
2014 
T: GBR T: 0   
No cases with exposure or infection of the membrane. 
Yu et al. 2016 T: Onlay T: 33.3 6 patients required additional grafting (28.6%). 1 patient 
presented a membrane exposure (4.76%). 
Jensen et 
al.2002 
T: Inter-positional 
graft 
T: 46.7-60 Relapse of the segment occurred in 14 segments (46.7%), with 1 
presenting a complete regression (the remaining < 1mm). 
Secondary bone grafting was required in 18 patients (60%). 
Anitua et al. 
2013 
T: Particulate graft 
only 
T: 0 No cases with impaired function of the alveolar nerve.  
Canullo & 
Malagnino  
2008 
T: GBR T: 10 1 patient presented a late exposure at 5 months that was cleaned 
during one month. The VBG was assured and implants could be 
placed. 
Funato et al. 
2013 
T: GBR with Ti-mesh T: 15.8 1 early wound dehiscence that needed Ti-mesh removal. 1 late 
Ti-mesh exposure. 1 case without mature bone for implant 
placement (GBR was needed again) 
 
Fontana et al. 
2015 
T: GBR T: 17.2  3 cases with early membrane exposure (2 had to be immediately 
removed and 1 was postponed 4 weeks). 2 cases with infection 
without membrane exposure (membranes were immediately 
removed). 
Froum et al. 
2008 
T: Distraction T: 73.3 18 patients required additional bone augmentation. 22 patients 
failed to achieve buccal augmentation or presented a palatal 
movement of the transport segment. 4 patients had flap 
dehiscence. 2 patients had distractor instability. 2 patients had 
infection. 8 patients had resorption of the transport segment. 
Simion et al. 
2001 
T: GBR  T: 17.3 7 patients presented membrane exposure (13.5%). 2 patients 
presented local infection (3.8%). 
Urban et al. T: GBR T: 2.8  1 patient presented a local infection. 
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2009 
Beitlitum et 
al. 2010 
T: GBR 
C: GBR 
T: 25 
C: 33.3 
T: 2 cases with membrane exposure. 
C: 5 cases with membrane exposure. 
* 12.5% of patients receiving a mandibular procedure had 
transitory paraesthesia. 
Rocchietta et 
al. 2016 
T: Onlay + membrane 
C: GBR 
T: 8.3 
C: 8.3 
1 patient presented an abscess that affected sites test and 
control sites. The membrane had to be removed together with 
the grafts. 
Roccuzzo et 
al. 2007 
T: Onlay + Ti-mesh 
C: Onlay 
 
T: 33.3 
C: 58.33 
T: 4 patients presented mesh exposure. 
C: 1 Graft mobilization at implant placement (8,3%). 3 incomplete 
integration of the graft (25%). 1 temporary parethesia (8,3%). 2 
significant graft resorption (16,7%).  
Simion et al. 
1998 
T: GBR 
C: GBR 
T: 20 
C: 20 
T: 2 patients presented membrane exposure. 
C:  1 patient presented membrane exposure and 1 patient 
presented local infection/abscess. 
Abrahamsson 
et al. 2012 
T: GBR 
C: Onlay 
 
T: 40 
C: 0 
T: 2 cases with perforation of the soft tissue expander and 2 
patients with exposure of the titanium mesh.  
C: No single complication. 
Merli et al. 
2007 
GBR 
(Particulate) 
 
T: 36.4 
C: 45.4  
T: 2 major complications: local infections with failure of the 
augmentation procedure. 2 minor complications (flap dehiscence 
without suppuration and early infection) which didn’t jeopardize 
the augmentation procedure.  
C: 1 major complication: Dehiscence + infection with failure of 
the procedure. 4 Minor complications: 3 Fistulas at different time 
points (2 weeks, 2 months with re-entry and at abutment 
connection) and 1 lymph node swelling.  
Ronda et al. 
2014 
T: GBR T: 0 No single complication. 
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C: GBR C: 0 
Cucchi et al. 
2017 
T: GBR 
C: GBR 
 
T: 21 
C: 15 
T: 3 major complications: abscess without exposition, early 
exposure with infection, and late exposure with infection. 1 
minor complication: late exposure without infection. 
C: 2 major complications: 1 abscess without exposition and 1 
early membrane with infection. 1 minor complication:  late 
membrane exposure without infection. 
Leong et al. 
2015 
T: Onlay + membrane 
C: GBR 
T: 77.8 
C: 30 
T: 7 out of 9 blocks presented soft tissue dehiscence and incision 
line openings. 1 block was lost. 
C: 3 out of 10 surgical sites experiences wound dehiscence and 
incision line opening. 
Fontana et al. 
2008 
T: GBR 
C: GBR 
T: 20 
C: 20 
T: 1 case presented paraesthesia that solved spontaneously 
before two months. 
C: 1 case with infection without membrane exposure that had to 
be removed. Implants could be placed. 
 
T: Test; C: Control; GBR: guided bone regeneration; VBA: vertical bone augmentation; Ti: titanium. 
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Table 5. Meta-analysis for prevalence of complications (%) by intervention. 
 
Group:Subgroup n Weighted Mean Incidence Heterogeneity 
IV DL 95% CI P value I2 P value 
All 29  16.9 12.5 21.2 <0.001 80.0 <0.001 
Study design         
RCT (all) 6  23.2  12.2 34.3 <0.001 73.6 <0.001 
RCT (split) 1 20.0   0.0 44.8 <0.001 - - 
RCT (parallel) 5  24.0 11.7 36.2 <0.001 78.2 <0.001 
CCT 4  23.3 12.0 34.5 <0.001 83.4 <0.001 
Case Series 18  13.6 7.8 19.4 <0.001 80.9 <0.001 
Time of implant placement         
Staged 15  22.3 13.4 31.3 <0.001 84.4 <0.001 
Simultaneous 11  11.8 6.7 17.0 <0.001 49.8 0.010 
Intervention         
1. Distraction osteogenesis 3  47.3 0.0 98.0 <0.001 95.9 0.047 
2. Guided Bone Regeneration 20  12.1 8.2 15.9 <0.001 42.7 0.010 
2.1. Non resorbable membrane 13 6.9  4.1 9.7 <0.001 22.6 0.186 
2.1.1. Non resorbable membrane 
(PTFE-e) 
11 8.0  4.7 11.3 <0.001 23.6 0.192 
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2.1.2. Non resorbable membrane 
(PTFE-d) 
3 4.1  0.0 9.4 <0.001 6.2 0.344 
2.2. Resorbable membrane 8  22.7 11.5 33.9 <0.001 63.9 0.005 
2.2.1. Resorbable membrane + 
space maintainer (Ti-mesh/plate) 
4 23.3  12.7 33.8 <0.001 0.0 0.417 
2.2.2. Resorbable membrane 
without space maintainer 
4  21.0 4.2 37.9 <0.001 68.6 0.013 
2.2.3. Native collagen resorbable 
membrane 
4  24.4 1.3 47.4 0.019 77.1 0.004 
2.2.4. Cross-linked resorbable 
membrane 
4 22.4  12.9 32.0 <0.001 0.0 0.807 
2.3. Titanium mesh 1 20.0  0.0 44.8 <0.001 - - 
3. Blocks 9  23.9 11.3 36.6 <0.001 83.1 <0.001 
3.1. Autologous bone block 6  22.9 9.1 36.8 0.006 75.8 <0.001 
3.1.1. Autologous onlay block 4  26.1 7.2 45.0 0.007 78.5 <0.001 
3.1.2. Shell technique 2  17.8 0.0 45.9 <0.001 82.5 0.017 
3.2. Allograft bone block 2  39.2 0.0 100 <0.001 96.3 <0.001 
3.3. Xenograft block 1 10.0  0.0 28.6 <0.001 - - 
4. Particulate synthetic graft 1 2.2  0.0 8.1 <0.001 - - 
 
IV, inverse-variance weighted (fixed effect) model; DL, DerSimonian and Laird (random effect) model; CI, confidence interval; RCT, randomized clinical trial; CCT, 
controlled clinical trial 
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
  
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
